Study Title
Pancreatic Cancer Early Detection Consortium (PRECEDE)
Study Number
PRECEDE
Enrollment status
Open
Categories
Cancer Control/Symptom Management, Pancreatic
Study Summary
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
Study Coordinator(s)
- Trupti, 309-243-3662, thattiangadi@illinoiscancercare.com
- Erica, 309-243-3626 eraynor@illinoiscancercare.com